Bilici, AhmetSelçukbiricik, FatihDemir, NazanÖven Ustaalioğlu, Bala BaşakDikillitaş, MustafaYıldız, Özcan10.07.20192019-07-1010.07.20192019-07-102014Bilici, A., Selçukbiricik, F., Demir, N., Öven Ustaalioğlu, B. B., Dikillitaş, M. ve Yıldız, Ö. (2014). Modified docetaxel and cisplatin in combination with capecitabine (DCX) as first-tine treatment in HER2-negative advanced gastric cancer. 50th Annual Meeting of the American-Society-of-Clinical-Oncology, Chicago, IL: American Society of Clinical Oncology.0732-183X1527-7755https://hdl.handle.net/20.500.12511/303350th Annual Meeting of the American-Society-of-Clinical-Oncology -- MAY 30-JUN 03, 2014 -- Chicago, ILWOS: 000358613200461[Abstract Not Available]eninfo:eu-repo/semantics/closedAccessModified DocetaxelCisplatinCapecitabine (DCX)HER2-NegativeGastric CancerConference Object3215Q1